NSEPrice movement11 Sept 2026 · 11 Sept 2026, 09:38 am

Price movement

Astec LifeSciences Limited · ASTEC

✦ AI SummaryRegulatory

Astec LifeSciences Limited has responded to a notice from the National Stock Exchange of India Limited regarding significant price movement in the company's shares. The company confirms compliance with listing regulations and denies any developments requiring mandatory disclosure.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk3/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Significant movement in price has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Astec LifeSciences Limited has submitted their response.

Attachments (1)

📄

ASTEC_11092026093844_NSEReplyPrice_Movement11092026.pdf

pdf

Download →
View document text
Date: 11th September, 2026 National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051 NSE Symbol: “ASTEC” Dear Sir / Madam, Sub.: Reply on Significant Movement in Price across Exchanges, in the recent past Ref.: Your Notice Ref. No. NSE/CM/Surveillance/17535 dated 10th September, 2026 With reference to your captioned Notice bearing Ref. No.: NSE/CM/Surveillance/17535 dated 10th September, 2026, we wish to inform you that as a Listed Company, we are conscious of our responsibility to disseminate to the Stock Exchanges, information that could have an impact on the price of the Company’s shares. Consistent with this approach, we have been promptly disseminating to the Stock Exchanges, events or information which are required to be disclosed pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“the Listing Regulations”). We hereby confirm that we are in compliance with respect to disclosures that are required to be made under the Listing Regulations and also confirm that there are no developments that have taken place requiring mandatory disclosure under Listing Regulations or the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (“PIT Regulations”). Please be assured that as a responsible corporate citizen we would fully comply with our obligations under the Listing Regulations and / or PIT Regulations and would make appropriate disclosures as mandated under the applicable regulations as and when required. Kindly take the above information on your records. Thanking you, Yours sincerely, For Astec LifeSciences Limited Tejashree Pradhan Company Secretary & Compliance Officer (FCS 7167)